← FDA DRUG APPROVALS

FDA ANDA · ANDA070189

NALOXONE

Sponsor: WYETH AYERST

APPLICATION
ANDA070189
TYPE
ANDA
ORIGINAL APPROVAL
1985-10-02
LATEST ACTION
1988-01-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

NALOXONEDiscontinued
NALOXONE HYDROCHLORIDE 0.02MG/ML · INJECTABLE · INJECTION

Approval history

1988-01-22Manufacturing (CMC) · Supplement 2AP
1987-06-05Manufacturing (CMC) · Supplement 4AP
1987-02-20Manufacturing (CMC) · Supplement 3AP
1985-10-02OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →